PTPRC and cancer: To confirm that the expression of these 16 genes was reduced in metastatic cancer cells following tumor formation, we performed RNA sequencing from isolated non-immune cell-enriched (CD45-negative) and immune cell-enriched (CD45-positive) from 66cl4 and 67NR tumors.